New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
February 25, 2013
04:55 EDTAET, AET, AET, SGYP, SGYP, SGYP, SYK, SYK, SYK, EW, EW, EW, CCXI, CCXI, CCXI, INFI, INFI, INFI, QSII, QSII, QSII, SIAL, SIAL, SIALCitigroup to host a conference
Global Healthcare Conference is being held in New York on February 25-27.
News For EW;CCXI;INFI;QSII;SIAL;AET;SGYP;SYK From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
1 | 2 | 3 | 4 | all recent news | >>
June 25, 2015
14:44 EDTAETHumana options active on nearing deal to be acquired by Aetna
Subscribe for More Information
13:57 EDTAETHumana spikes on nearing deal to be acquired by Aetna
Subscribe for More Information
13:53 EDTAETHumana nearing deal to be acquired by Aetna, Bloomberg reports
Aetna (AET) is nearing an acquisition of Humana (HUM) and a deal could be reached as early as this weekend, Bloomberg reports, citing people with knowledge of the matter. Aetna's bid includes cash and stock, and talks between the two the companies picked up after Anthem (ANTM) came public with a bid for Cigna (CI), Bloomberg adds. Both Aetna and Cigna bid for Humana, a source told Bloomberg, with Humana's board preferring the offer from Aetna. Shares of Humana are up $14.72 to $198.95 following Bloomberg's report. Reference Link
13:43 EDTAETHumana received offer from Cigna, Aetna, prefers Aetna, Bloomberg says
Subscribe for More Information
13:43 EDTAETAetna nearing deal to acquire Humana, Bloomberg reports
11:06 EDTAETHospitals, insurers climb after Supreme Court rules on ACA subsidies
Subscribe for More Information
10:11 EDTAETACA tax subsidies upheld by Supreme Court
The decision of the Fourth Circuit was affirmed in King v. Burwell by a vote of 6 to 3, according to multiple media reports. The Supreme Court upholding the lower court ruling means that individuals who get health insurance through an exchange established by the federal government will be eligible for tax subsidies in all 50 states. Publicly traded companies in the health insurance space include Aetna (AET), Anthem (ANTM), Centene (CNC), Cigna (CI), Health Net (HNT), Humana (HUM), Molina Healthcare (MOH), UnitedHealth (UNH) and WellCare (WCG). Publicly traded companies in the hospital space include Community Health (CYH), HCA Holdings (HCA), LifePoint (LPNT), Tenet (THC) and Universal Health (UHS).
09:40 EDTAETMultiple parties expressing interest in Humana, CNBC reports
Humana (HUM) has received expressions of interest from multiple companies, CNBC's David Faber reports. The interest does not mean multiples bids are forthcoming, Faber added.
June 24, 2015
17:57 EDTAETWall Street applauds Senate giving go-ahead for 'fast track' trade powers
Subscribe for More Information
10:00 EDTAETOn The Fly: Analyst Initiation Summary
Subscribe for More Information
06:36 EDTAETAetna initiated with a Sector Perform at RBC Capital
Subscribe for More Information
05:59 EDTSGYPStocks with implied volatility below IV index mean; SGYP WMB
Subscribe for More Information
June 23, 2015
11:20 EDTEWMedtronic competitive with Edwards after approval, says Wells Fargo
Subscribe for More Information
10:30 EDTSGYPOptions with decreasing implied volatility
Subscribe for More Information
09:14 EDTSGYPOn The Fly: Pre-market Movers
Subscribe for More Information
07:44 EDTAETHumana takeover looks unlikely below $210/share, says Leerink
Subscribe for More Information
07:25 EDTEWPiper Jaffray to hold a summit
2015 Piper Jaffray Heartland Summit is being held in Minneapolis on June 23-24.
07:17 EDTEWFeedback on Edwards Lifesciences Centera 'very positive,' says Wells Fargo
Subscribe for More Information
06:36 EDTSGYPSynergy Pharmaceuticals volatility elevated
Subscribe for More Information
06:02 EDTSGYPSynergy Pharma begins second of two Phase 3 clinical trials of plecanatide
Synergy Pharmaceuticals announced the initiation of the second of two pivotal phase 3 clinical trials evaluating the efficacy and safety of two different plecanatide treatment doses, taken as a tablet once-a-day, in patients with irritable bowel syndrome with constipation, or IBS-C. The phase 3 IBS-C program includes two randomized, 12-week, double-blind, placebo-controlled pivotal trials conducted in the U.S. and each trial is expected to enroll approximately 1050 adult patients with IBS-C.
1 | 2 | 3 | 4 | all recent news | >>

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use